Rastreio do Cancro do Pulmão, para quando?

Aberle DR, Adams AM, Berg CD, et al National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. doi: 10.1056/NEJMoa1102873 pmid: 21714641

de Koning HJ, van der Aalst CM, de Jong PA, etal. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med 2020;382:503-13. doi: 10.1056/NEJMoa1911793 pmid: 31995683

Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer 2020;146:1503-13.

Pastorino U, Silva M, Sestini S, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019;30:1162-9.

Kovalchik S, Tammemagi,M et al. Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death. N Engl J Med 2013;369:245-54

Henschke, C. I. et al. CT screening for lung cancer: part-solid nodules in baseline and annual repeat rounds. Am. J. Roentgenol. 207, 1176-84 (2016).

Alexandra L Potter,1 Allison L Rosenstein,1 Mathew V Kiang, et al. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study BMJ 2022;376:e069008.